Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bryant

Showing results (251-260 of 307) with videos related to

Pageof 31
Sort By:
Practical Radiation Oncology|July 11, 2024
Quantifying the Risk of Technology-Driven Health Disparities in Radiation OncologyAlexander Moncion, Alex K Bryant, Carlos E Cardenas, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Journal of Oncology Practice|August 23, 2017
Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced CancerDaniel P Triplett, Wendi G LeBrett, Alex K Bryant, et al.
Parasitology Research|September 12, 2014
In vitro culture of Parascaris equorum larvae and initial investigation of parasite excretory-secretory productsSteffanie V Burk, Sriveny Dangoudoubiyam, Tammy Brewster-Barnes, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2019
Tobacco smoking and death from prostate cancer in US veteransPaul Riviere, Abhishek Kumar, Elaine Luterstein, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 30, 2014
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver functionDavid P Dorn, Mary K Bryant, Jessica Zarzour, et al.
Cancer|May 5, 2018
Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapyAlex K Bryant, Anthony V D'Amico, Paul L Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate CancerAlex K Bryant, Andrew K Kader, Rana R McKay, et al.
Medical Care|February 27, 2019
Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record DataRanier Bustamante, Ashley Earles, James D Murphy, et al.
Cancer|November 6, 2023
Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White menKyung Min Lee, Alex K Bryant, Julie A Lynch, et al.
Pageof 31

Showing results (251-260 of 307) with videos related to

Sort By:
Pageof 31
Practical Radiation Oncology|July 11, 2024
Quantifying the Risk of Technology-Driven Health Disparities in Radiation OncologyAlexander Moncion, Alex K Bryant, Carlos E Cardenas, et al.
Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.
Journal of Oncology Practice|August 23, 2017
Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced CancerDaniel P Triplett, Wendi G LeBrett, Alex K Bryant, et al.
Parasitology Research|September 12, 2014
In vitro culture of Parascaris equorum larvae and initial investigation of parasite excretory-secretory productsSteffanie V Burk, Sriveny Dangoudoubiyam, Tammy Brewster-Barnes, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2019
Tobacco smoking and death from prostate cancer in US veteransPaul Riviere, Abhishek Kumar, Elaine Luterstein, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 30, 2014
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver functionDavid P Dorn, Mary K Bryant, Jessica Zarzour, et al.
Cancer|May 5, 2018
Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapyAlex K Bryant, Anthony V D'Amico, Paul L Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate CancerAlex K Bryant, Andrew K Kader, Rana R McKay, et al.
Medical Care|February 27, 2019
Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record DataRanier Bustamante, Ashley Earles, James D Murphy, et al.
Cancer|November 6, 2023
Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White menKyung Min Lee, Alex K Bryant, Julie A Lynch, et al.
Pageof 31